🔎 Trials Near Me

Pradžia › Ūmi limfoblastinė leukemija › Ilinoisas › Chicago

Ūmi limfoblastinė leukemija klinikiniai tyrimai Chicago, IL

19 tyrimai dėl Ūmi limfoblastinė leukemija ieško dalyvių vietose Chicago ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
  • Mount Sinai Hospital Medical Center, Chicago
  • John H Stroger Jr Hospital of Cook County, Chicago
  • University of Illinois, Chicago
  • ir dar 1
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05334069

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Renkami dalyviai1/2 fazė
  • The University of Chicago Medical Center, Chicago
30 Days · Visoms lytims · Atnaujinta 2026-09-16 · NCT04065399

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Renkami dalyviai1/2 fazė
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Iki 22 metų · Visoms lytims · Atnaujinta 2026-08-25 · NCT04726241

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Renkami dalyviai2 fazė
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Amžius nuo 7 iki 25 · Visoms lytims · Atnaujinta 2026-08-19 · NCT05082519

A Study of CTD402 in T-ALL/LBL Patients

Renkami dalyviai1/2 fazė
  • University of Chicago, Chicago
Amžius 1 ir vyresni · Visoms lytims · Atnaujinta 2026-08-19 · NCT07070219

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Renkami dalyviaiStebimasis tyrimas
  • The University of Chicago, Chicago
1 Day – 17 Years · Visoms lytims · Atnaujinta 2026-08-14 · NCT06274788

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

Renkami dalyviai1/2 fazė
  • Research Site, Chicago
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-07-13 · NCT07109219

Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia

Renkami dalyviai
  • University of Chicago Medicine Comprehensive Cancer Center, Chicago
Amžius 15 ir vyresni · Visoms lytims · Atnaujinta 2026-07-10 · NCT06446661

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Renkami dalyviaiStebimasis tyrimas
  • Northwestern Memorial Hospital, Chicago
  • Rush University Medical Center, Chicago
  • University of Illinois at Chicago, Chicago
  • ir dar 2
Visi amžiai · Visoms lytims · Atnaujinta 2026-07-06 · NCT01351545

Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

Renkami dalyviai
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
Amžius 14 ir vyresni · Visoms lytims · Atnaujinta 2026-06-30 · NCT03932903

Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia

Renkami dalyviai1 fazė
  • University of Chicago Medical Center, Chicago
Amžius nuo 18 iki 39 · Visoms lytims · Atnaujinta 2026-06-29 · NCT03571321

Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)

Renkami dalyviai2 fazė
  • University of Chicago Medical Center, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-05 · NCT04747912

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Renkami dalyviaiStebimasis tyrimas
  • Lurie Children's Hospital-Chicago, Chicago
Visi amžiai · Visoms lytims · Atnaujinta 2026-05-18 · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Renkami dalyviai1 fazė
  • University of Chicago, Chicago
Amžius 13 ir vyresni · Visoms lytims · Atnaujinta 2026-05-05 · NCT04771572

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Renkami dalyviai1/2 fazė
  • Northwestern, Chicago
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-03-24 · NCT04988555

A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

Renkami dalyviai1/2 fazė
  • University of Chicago Medicine Comprehensive Cancer Center, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-18 · NCT06207123

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Renkami dalyviai2 fazė
  • University of Chicago Comprehensive Cancer Center, Chicago
Amžius nuo 18 iki 54 · Visoms lytims · Atnaujinta 2026-03-17 · NCT06918431

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Renkami dalyviai1 fazė
  • Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Amžius nuo 1 iki 40 · Visoms lytims · Atnaujinta 2026-03-12 · NCT05292664

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Renkami dalyviai1 fazė
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Amžius nuo 1 iki 21 · Visoms lytims · Atnaujinta 2024-12-06 · NCT05476770

Ūmi limfoblastinė leukemija tyrimai kituose miestuose

Kiti tyrimai Chicago

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.